ANAXOR

pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hemoglobin; medicines for human purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; drugs for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia